Development of vaccines for Candida albicans: fighting a skilled transformer

  title={Development of vaccines for Candida albicans: fighting a skilled transformer},
  author={Antonio Cassone},
  journal={Nature Reviews Microbiology},
Two univalent subunit vaccines that are based on major virulence traits of Candida albicans have completed Phase I clinical trials in recent years. Although it is hoped that at least one will become the first antifungal vaccine approved for human use, there are some major obstacles to achieving this. The difficulties mostly arise from the remarkable ability of C. albicans to deceive the host immune system. In this Opinion article, I argue that the development of a multivalent vaccine that… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
22 Citations
74 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 22 extracted citations


Publications referenced by this paper.
Showing 1-10 of 74 references

Adjuvanticity of recombinant calreticulin fragment 39–372 in assisting anti‐ β-glucan IgG responses in T cell deficient mice

  • Li, K. W. Long, X. Gao
  • Clin. Vacc. Immunol
  • 2013

results from an internal panel survey

  • B. Foxman, R. Muraglia, +4 authors the United States
  • J. Low. Genit. Tract Dis. 17, 340–345
  • 2013

Similar Papers

Loading similar papers…